EUVIMEDOpdag EUVIMED
Übersichtsarbeit

Artificial Intelligence in Diabetes Care

Michal Dubský iD, Michaela Liegertová, Robert Bém, Dominika Sojáková, Vladimíra Fejfarová, Edward B Jude iD

Diabetes, Obesity and Metabolism · 2026

DOI: 10.1111/dom.70720 ↗

At a glance

Übersichtsarbeit in Diabetes, Obesity and Metabolism, 2026. Written by Michal Dubský and 5 co-authors. Institution: Diabetes Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. Major MEDLINE topics: Artificial Intelligence, Diabetes Mellitus, Diabetes Mellitus, Type 1. Cited 5 times so far (Crossref); 68 references. Funded by: National Institute for Research on Metabolic and Cardiovascular Diseases, European Union Next-Generation EU.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Diabetes care requires frequent and high‐stakes decisions that must be made in the setting of substantial day‐to‐day physiologic variability. The growing availability of continuous glucose monitoring, connected insulin delivery devices and longitudinal electronic health record data has created an opportunity for algorithm‐enabled tools that can synthesise high‐frequency data, reduce cognitive burden for patients and clinicians, and support safer and more consistent decision‐making.

Aim

In this review, artificial intelligence (AI) is used broadly to describe computational systems that generate predictions, recommendations or automation from clinical data.

Methods

We distinguish between algorithmic automation and control methods that underpin many currently deployed automated insulin delivery (AID) systems and machine learning–based models, including deep learning and large language models (LLMs), that are increasingly used for pattern recognition, risk prediction and natural language applications.

Results

This distinction is clinically relevant because evidence standards, safety risks and governance needs vary substantially across these categories.

Conclusion

This narrative review summarises current and emerging applications of AI in diabetes care with an emphasis on clinical readiness, strength of evidence and implementation considerations. We highlight established applications in AID, emerging approaches that seek greater autonomy and interoperability and newer tools such as LLMs, wearables and digital twin frameworks, focusing on where evidence is strongest, where risks are highest and what safeguards are required for responsible clinical use.

Subjects

MeSH terms (MEDLINE)

Artificial IntelligenceDiabetes MellitusDiabetes Mellitus, Type 1HumansInsulin Infusion SystemsContinuous Glucose MonitoringInsulinLarge Language ModelsIntelligent SystemsDigital HealthHypoglycemic AgentsAlgorithmsMachine Learning

Author keywords

glycaemic controlinsulin pump therapyrisk predictiontype 1 diabetes

Substances

InsulinHypoglycemic Agents

Authors and institutions

  • Diabetes Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
  • First Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Faculty of Science, Jan Evangelista Purkyně University, Ústí nad Labem, Czech Republic.
  • Second Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Diabetes Center, Tameside and Glossop Integrated Care NHS Foundation Trust and University of Manchester, Ashton-under-Lyne, Lancashire, UK.

ORCID profiles: Michal Dubský, Edward B Jude

Funding

  • National Institute for Research on Metabolic and Cardiovascular Diseases
  • European Union Next-Generation EU

Cite

APA

Dubský, M., Liegertová, M., Bém, R., Sojáková, D., Fejfarová, V., & Jude, E. B. (2026). Artificial Intelligence in Diabetes Care. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70720

Vancouver

Dubský M, Liegertová M, Bém R, Sojáková D, Fejfarová V, Jude EB. Artificial Intelligence in Diabetes Care. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.70720

BibTeX
@article{Dubsk2026,
  author = {Dubský, Michal and Liegertová, Michaela and Bém, Robert and Sojáková, Dominika and Fejfarová, Vladimíra and Jude, Edward B},
  title = {Artificial Intelligence in Diabetes Care},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  doi = {10.1111/dom.70720}
}
Start for free →